Tag: Novartis Oncology

Siemens’ Biograph mMR system

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

June 12, 2011

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid

READ MORE
Novartis logo

Breaking News: FDA Approves Treatment for pNET Patients

May 5, 2011

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET…

READ MORE
novartis-oncology-logo

Carcinoid Cancer Foundation Thanks Symposium Sponsors

April 21, 2011

There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual  symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City.  The Foundation…

READ MORE
CNETS Halifax 2011 Conference

CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals

April 1, 2011

Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…

READ MORE
Monica Warner (right) and Maryann Wahmann

Novartis Oncology Announces Winner of 2010 Warner Advocacy Award

September 27, 2010

Maryann Wahmann of the Carcinoid Cancer Awareness Network (CCAN) has been chosen as winner of the 2010 Warner Advocacy Award, established last year by Novartis Oncology to commemorate the life and work of the late Monica Warner of the Carcinoid Cancer

READ MORE
Sanofi_GoMeals_iPhone_app

12 iPhone Apps for Patients and Physicians

July 27, 2010

For carcinoid and neuroendocrine cancer iPhone users there are many resources for you as a patient or for your physician that have been created by big pharmaceutical companies around the world.  These pharma companies include Novartis, Pfizer, Merck

READ MORE
MonicaWarner(2) best headshot

Advocacy Award Honors the Late Monica Warner of the Carcinoid Cancer Foundation: Call for Nominations

June 15, 2010

Novartis Oncology has announced its 2010 Warner Advocacy Award named in honor of Monica Warner, a driving force behind the Carcinoid Cancer Foundation for two decades and an extraordinary advocate for carcinoid and neuroendocrine tumor patients. …

READ MORE

Sandostatin Mobile Administration Program for Carcinoid Syndrome Patients

February 18, 2010

If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program.  This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…

READ MORE
2009 Kenner Conference Logo

Video Recording of National Carcinoid Cancer and Neuroendocrine Tumor Patient Conference Now Online

January 19, 2010

Whether you are newly diagnosed with carcinoid cancer or another neuroendocrine tumor or you are seeking novel treatments for NETs you can gain invaluable information from the video recording of the 2009 National Carcinoid/NET Patient Conference

READ MORE